Our understanding of the association between SphK1 expression in normal and malignant breast cells [12, 27] and this added knowledge that SphK-1a and -1b are expressed in estrogen-responsive normal and breast cancer tissue provides another avenue to explore anti-SphK novel targeted therapeutic intervention. This evidence concerns the gene SPHK1 and breast carcinoma.